Women who have inherited pathogenic variants (mutations) in the BRCA1 and BRCA2 genes (BRCA1/2) face a very high lifetime risk of developing breast cancer (BC) and/or ovarian cancer (OC). The gene discussed is BRCA1; the disease is breast carcinoma.